Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing
Authors:
- Jeff S. HealeyJHJeff S. Healey
- Paul DorianPDPaul Dorian
- Mario TalajicMTMario Talajic
- Andre LamyALAndre Lamy
- Magdy BastaMBMagdy Basta
- Xiaoyin WangXWXiaoyin Wang
- 26 January 2010
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 21 (2) , 177-182
Abstract
Defibrillation Testing at ICD Implantation. Background: There is uncertainty about the proper role of defibrillation testing (DT) at the time of implantable cardioverter defibrillator (ICD) insertion. Methods: A prospective registry was conducted at 13 sites in Canada between January 2006 and October 2007. Objectives: To document the details of DT, the reasons for not conducting DT, and the costs and complications associated with DT. Results: DT was conducted at implantation in 230 of 361 patients (64%). DT was more likely to be conducted for new implants compared with impulse generator replacements (71% vs 32%, P = 0.0001), but was similar for primary and secondary prevention indications (64% vs 63%, P = NS). Among patients not having DT, the reason(s) given were: considered unnecessary (44%); considered unsafe, mainly due to persistent atrial fibrillation (37%); lack of an anesthetist (20%); and, patient or physician preference (6%).When performed, DT consisted of a single successful shock ≥ 10J below maximum device output in 65% of cases. A 10J safety‐margin was met by 97% of patients, requiring system modification in 2.3%. Major perioperative complications occurred in 4.4% of patients having DT versus 6.6% of patients not having DT (P = NS). ICD insertion was $844 more expensive for patients having DT (P = 0.16), largely due to increased costs ($28,017 vs $24,545) among patients having impulse generator replacement (P = 0.02). Conclusions: DT was not performed in a third of ICD implants, usually due to a perceived lack of need or relative contraindication. (J Cardiovasc Electrophysiol, Vol. 21, pp. 177‐182, February 2010)Keywords
This publication has 11 references indexed in Scilit:
- No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)JACC, 2008
- Defibrillation Threshold Testing in Implantable Cardioverter-DefibrillatorsJACC, 2008
- Complications associated with defibrillation threshold testing: The Canadian experienceHeart Rhythm, 2008
- Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov ModelJournal of Cardiovascular Electrophysiology, 2008
- Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide surveyEP Europace, 2007
- Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy DefibrillatorsCirculation, 2007
- Intraoperative Testing of the Implantable Cardioverter‐Defibrillator: How Much Is Enough?Journal of Cardiovascular Electrophysiology, 2005
- Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?Heart Rhythm, 2005
- Is defibrillation testing required for defibrillator implantation?JACC, 2004
- High Defibrillation Thresholds in Transvenous Biphasic Implantable Defibrillators:Pacing and Clinical Electrophysiology, 2003